U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) has been given a consensus recommendation of “Buy” by the six analysts that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $109.00.
A number of equities analysts have recently commented on USPH shares. JMP Securities reiterated a “market outperform” rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JPMorgan Chase & Co. cut their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, March 19th. Barrington Research reduced their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Finally, Wall Street Zen upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th.
Check Out Our Latest Stock Analysis on U.S. Physical Therapy
U.S. Physical Therapy Price Performance
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to analysts’ expectations of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. U.S. Physical Therapy’s revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.51 earnings per share. On average, analysts predict that U.S. Physical Therapy will post 2.67 EPS for the current year.
U.S. Physical Therapy Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy’s payout ratio is 82.57%.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in USPH. CBIZ Investment Advisory Services LLC raised its holdings in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after acquiring an additional 122 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in U.S. Physical Therapy by 952.4% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock worth $32,000 after purchasing an additional 400 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at about $39,000. Venturi Wealth Management LLC raised its stake in shares of U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the period. Finally, Fifth Third Bancorp lifted its holdings in shares of U.S. Physical Therapy by 34.6% in the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock valued at $75,000 after purchasing an additional 265 shares in the last quarter.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Stories
- Five stocks we like better than U.S. Physical Therapy
- How to Calculate Options Profits
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
- How to Invest in Biotech Stocks
- Government Mandate Sends eVTOL Stocks Flying
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.